The DYT1 gene containing a trinucleotide deletion (DGAG) is linked to early-onset dystonia, a neurological movement disorder of involuntary muscle contractions. To understand DYT1's contribution to dystonia, we produced and analyzed Dyt1 knockdown (KD) mice that expressed a reduced level of torsinA protein encoded by Dyt1. Knockdown mice exhibited deficits in motor control and a decreased trend in dopamine with a significant reduction in 3,4-dihydroxyphenylacetic acid. These alterations are similar to those displayed by previously reported Dyt1 DGAG knockin heterozygous mice, suggesting that the partial loss of torsinA function contributes to the pathology of the disease. # 2006 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.
A trinucleotide deletion (DGAG) in the DYT1 gene is found in a majority of patients with Oppenheim's early-onset dystonia, a neurological disorder of uncontrollable muscle contractions (Ozelius et al., 1997) . DYT1 codes for torsinA protein, and the DGAG deletion removes a glutamic acid (DE) from the protein. The role of mutant torsinA in the development of dystonia is unknown, but possible functions of normal torsinA were reported to include its involvement in cytoskeletal dynamics, nuclear membrane formation, and neuroprotection (Kuner et al., 2003; Bragg et al., 2004; Gonzalez-Alegre and Paulson, 2004; Goodchild and Dauer, 2004; Naismith et al., 2004; Shashidharan et al., 2004; Hewett et al., 2006; Kock et al., 2006) . Also unknown is the nature of the genetic mutation in torsinA, an important aspect of the pathophysiology of dystonia that may affect the development of genetic-based therapeutics.
The DGAG mutation of DYT1 has been speculated to work through a toxic-gain-of-function mechanism by reports of protein aggregates caused by an overexpression of mutant torsinA in cultured cells and Drosophila (Hewett et al., 2000; Kustedjo et al., 2000; Koh et al., 2004) . Also, in patient tissues and two mouse models, an overexpression transgenic and our Dyt1 DGAG knockin (Dyt1 DGAG) mouse lines, aggregates containing torsinA and ubiquitin were found primarily in the brainstem, even though torsinA is widely expressed throughout the brain (McNaught et al., 2004; Dang et al., 2005; Shashidharan et al., 2005) . In contrast, other published findings have suggested that DGAG causes a loss of normal protein function (Torres et al., 2004; Goodchild et al., 2005) . For example, nuclear envelope abnormalities were noted in neurons of Dyt1 knockout and homozygous Dyt1 DGAG mice, indicating that the mutant protein may be equivalent to the absence of the protein (Goodchild et al., 2005) .
To further address the genetic mechanism of the DGAG mutation, we report behavioral and biochemical analyses of Dyt1 knockdown (KD) mice that displayed motor deficits similar to the behavioral phenotype previously shown in our Dyt1 DGAG mice that carry one mutant allele. This is the first report to demonstrate that reducing torsinA expression can lead to abnormal motor development and biochemical changes in the brain.
All experimental procedures in this report were carried out in compliance with the USPHS Guide for Care and Use of Laboratory Animals and approved by University of Illinois Institutional Animal Care and Use Committee.
Dyt1 KD mouse was generated in the process of making Dyt1DGAG mice (Dang et al., 2005) . The targeting vector used had the implicated GAG removed in exon 5 of Dyt1 and a STOP sequence (Lakso et al., 1992) 
